Vaccination in the Neonatal Period and Early Infancy

References

• Stoll B. J., Lee F. K., Hale E., Schwartz D., Holmes R., Ashby R., Czerkinsky C., Nahmias A. J. Immunoglobulin secretion by the normal and the infected newborn infant. J. Pediatr. 1993; 122: 780–786
   Web of Science ®Google Scholar
• Watts A. M., Stanley J. R., Shearer M. H., Hefty P. S., Kennedy R. C. Fetal immunization of baboons induces a fetal-specific antibody response. Nat. Med. 1999; 5: 427–430
   PubMedGoogle Scholar
• Gans H. A., Arvin A. M., Galinus J., Logan L., De R., HovitzMaldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 1998; 280: 527–532
   PubMed Web of Science ®Google Scholar
• Booy R., Aitken S. J., Taylor S., Tudor G., WilliamsMacfarlane J. A., Moxon E. R., Ashworth L. A., Mayon R. T., WhiteGriffiths H., Chapel H. M. Immunogeni-city of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet 1992; 339: 507–510
   PubMed Web of Science ®Google Scholar
• Dong D. X., Hu X. M., Liu W. J., Li J. S., Jin Y. C., Tan S. G., Chen T. Q., Fu J. Z., Niu B. Y., Yu H. M. Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin). Bull. World Health Organ. 1986; 64: 853–860
   Google Scholar
• Lieberman J. M., Greenberg D. P., Wong V. K., Partridge S., Chang S. J., Chiu C. Y., Ward J. I. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. J. Pediatr. 1995; 126: 198–205
   PubMed Web of Science ®Google Scholar
• Kurikka S., Kayhty H., Peltola H., Saarinen L., Eskola J., Makela P. H. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatrics 1995; 95: 815–822
   PubMed Web of Science ®Google Scholar
• Schroeder H. W., Mortari F., Shiokawa S., Kirkham P. M., Elgavish R. A., Bertrand F. E. Developmental regulation of the human antibody repertoire. Am. NY Acad. Sci. 1995; 764: 242–260
   PubMed Web of Science ®Google Scholar
• Ridings J., Dinan L., Williams R., Roberton D., Zola H. Somatic mutation of immunoglobulin V(H)6 genes in human infants. Clin. Exp. Immunol. 1998; 114: 33–39
   Google Scholar
• Lucas A. H., Azmi F. H., Mink C. M., Granoff D. M. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide. J. Immunol. 1993; 150: 2056–2061
   Google Scholar
• Servet C., DelpratBridon J. M., Djossou O., Yahia S. A., Banchereau J., Briere F. Delayed IgG2 humoral response in infants is not due to intrinsic T or B cell defects. Int. Immunol. 1996; 8: 1495–1502
   Google Scholar
• Griffioen A. W., Franklin S. W., Zegers B. J., Rijkers G. T. Expression and functional characteristics of the complement receptor type 2 on adult and neonatal B lymphocytes. Clin. Immunol. Immunopathol. 1993; 69: 1–8
   PubMedGoogle Scholar
• Barrios C., Brawand P., Berney M., Brandt C., Lambert P. H., Siegrist C. A. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur. J. Immunol. 1996; 26: 1489–1496
   Google Scholar
• Brandt C., Power U. F., Plotnicky H., GilquinHuss T., Nguyen T., Lambert P. H., Binz H., Siegrist C. A. Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na. J. Infect. Dis. 1997; 176: 884–891
   Google Scholar
• Kovarik J., Bozzotti P., Love L., HomanPihlgren M., Davis H. L., Lambert P. H., Krieg A. M., Siegrist C. A. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming. J. Immunol. 1999; 162: 1611–1617
   PubMed Web of Science ®Google Scholar
• Barrios C., Brandt C., Berney M., Lambert P. H., Siegrist C. A. Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects. Eur. J. Immunol. 1996; 26: 2666–2670
   PubMed Web of Science ®Google Scholar
• Kovarik J., Siegrist C. A. Optimization of vaccine responses in early life: the role of delivery systems and immunomodulators. Immunol. Cell Biol. 1998; 76: 222–236
   PubMed Web of Science ®Google Scholar
• Martinez X., Brandt C., Saddallah F., Tougne C., Barrios C., Wild F., Dougan G., Lambert P. H., Siegrist C. A. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl. Acad. Sci. USA 1997; 94: 8726–8731
   PubMedGoogle Scholar
• Brazolot Millan C. L., Weeratna R., Krieg A. M., Siegrist C. A., Davis H. L. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. USA 1998; 95: 15553–15558
   PubMed Web of Science ®Google Scholar
• Siegrist C. A., Plotnicky H., GilquinCordova M., Berney M., Bonnefoy J. Y., Nguyen T. N., Lambert P. H., Power U. F. Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies. J. Infect. Dis. 1999; 179: 1326–1333
   PubMed Web of Science ®Google Scholar
• Siegrist C. A., Saddallah F., Tougne C., Martinez X., Kovarik J., Lambert P. H. Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells?. Vaccine 1998; 16: 1473–1478
   PubMed Web of Science ®Google Scholar
• Prescott S. L., Macaubas C., Holt B. J., Smallacombe T. B., Loh R., Sly P. O., Holt P. O. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J. Immunol. 1998; 160: 4730–4737
   PubMed Web of Science ®Google Scholar
• Malhotra I., Mungai P., Wamachi A., Kioko J., Ouma J. H., Kazura J. W., King C. L. Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J. Immunol. 1999; 162: 6843–6848
   PubMed Web of Science ®Google Scholar
• Juhela S., Hyoty H., Lonnrot M., Roivainen M., Simell O., Ilonen J. Enterovirus infections and enterovirus specific T-cell responses in infancy. J. Med. Virol. 1998; 54: 226–232
   PubMedGoogle Scholar
• Ausiello C. M., Urbani F., la Sala A., Lande R., Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 1997; 65: 2168–2174
   PubMed Web of Science ®Google Scholar
• Ryan M., Gothefors L., Storsaeter J., Mills K. H. Bordetella pertussis-specific Thl/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice. Dev. Biol. Stand. 1997; 89: 297–305
   Google Scholar
• Ildirim I., Sapan N., Cavusoglu B. Comparison of BCG vaccination at birth and at third month of life. Arch. Dis. Child. 1992; 67: 80–82
   PubMedGoogle Scholar
• Pabst H. F., Godel J. C., Spady D. W., Mc J., KechnieGrace M. Prospective trial of timing of bacillus Calmette-Guerin vaccination in Canadian Cree infants. Am. Rev. Respir. Dis. 1989; 140: 1007–1011
   Google Scholar
• Colditz G. A., Brewer T. F., Berkey C. S., Wilson M. E., Burdick E., Fineberg H. V., Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698–702
   PubMed Web of Science ®Google Scholar
• Colditz G. A., Berkey C. S., Mosteller F., Brewer T. F., Wilson M. E., Burdick E., Fineberg H. V. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995; 96: 29–35
   PubMed Web of Science ®Google Scholar
• Cans H. A., Maldonado Y., Yasukawa L. L., Beeler J., Audet S., Rinki M. M., De R., HovitzArvin A. M. IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. J. Immunol. 1999; 162: 5569–5575
   Google Scholar
• Chiba Y., Higashidate Y., Suga K., Honjo K., Tsutsumi H., Ogra P. L. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection. J. Med. Virol. 1989; 28: 133–139
   Google Scholar
• Wasik T. J., Jagodzinski P. P., Hyjek E. M., Wustner J., Trinchieri G., Lischner H. W., Kozbor D. Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection. J. Immunol. 1997; 158: 6029–6036
   Google Scholar
• Mbawuike I. N., Piedra P. A., Cate T. R., Couch R. B. Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine. J. Med. Virol. 1996; 50: 105–111
   Google Scholar
• Ridge J. P., Fuchs E. J., Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996; 271: 1723–1726
   PubMed Web of Science ®Google Scholar
• Sarzotti M., Robbins D. S., Hoffman P. M. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996; 271: 1726–1728
   PubMed Web of Science ®Google Scholar
• Forsthuber T, Yip H. C., Lehmann P. V. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996; 271: 1728–1730
   PubMed Web of Science ®Google Scholar
• Singh R. R., Hahn B. H., Sercarz E. E. Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity. J. Exp. Med. 1996; 183: 1613–1621
   PubMed Web of Science ®Google Scholar
• Donckier V., Flamand V., Desalle F., Vanderhaeghen M. L., de Veerman M., Thielemans K., Abramowicz D., Goldman M. IL-12 prevents neonatal induction of transplantation tolerance in mice. Eur. J. Immunol. 1998; 28: 1426–1430
   Google Scholar
• Arulanandam B. P., Van V. H., CleaveMetzger D. W. IL-12 is a potent neonatal vaccine adjuvant. Eur. J. Immunol. 1999; 29: 256–264
   PubMed Web of Science ®Google Scholar
• Flamand V., Donckier V., Demoor F. X., Le Moine A., Matthys P., Vanderhaeghen M. L., Tagawa Y., Iwakura Y., Billiau A., Abramowicz D., Goldman M. CD40 ligation prevents neonatal induction of transplantation tolerance. J. Immunol. 1998; 160: 4666–4669
   Google Scholar
• Albrecht P., Ennis F. A., Saltzman E. J., Krugman S. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J. Pediatr. 1977; 91: 715–718
   PubMed Web of Science ®Google Scholar
• Perkins F. T., Yetts R., Gaisford W. A comparison of the responses of 100 infants to primary poliomyelitis immunization with two and with three doses of vaccine. Br. Med. J. 1959; 1: 1083–1086
   Google Scholar
• Burstyn D. G., Baraff L. J., Peppier M. S., Leake R. D., St J. Geme, Manclark C. R. Serological response to filamentous hemagglutinin and lymphocy-tosis-promoting toxin o. Bordetella pertussis. Infect. Immun. 1983; 41: 1150–1156
   PubMed Web of Science ®Google Scholar
• Englund J. A., Anderson E. L., Reed G. F., Decker M. D., Edwards K. M., Pichichero M. E., Steinhoff M. C., Rennels M. B., Deforest A., Meade B. D. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995; 96: 580–584
   PubMed Web of Science ®Google Scholar
• Barr M., Glenny A. T., Randall K. J. Diphtheria immunisation in young babies. A study of some factors involved. Lancet 1950; ii: 6–10
   Google Scholar
• Sarvas H., Kurikka S., Seppala I. J., Makela P. H., Makela O. Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. J. Infect. Dis. 1992; 165: 977–979
   PubMed Web of Science ®Google Scholar
• Bjorkholm B., Granstrom M., Taranger J., Wahl M., Hagberg L. Influence of high liters of maternal antibody on the serologic response of infants to diphtheria vaccination at three, five and twelve months of age. Pediatr. Infect. Dis. J. 1995; 14: 846–850
   Google Scholar
• Claesson B. A., Schneerson R., Robbins J. B., Johansson J., Lagergard T., Taranger J., Bryla D., Levi L., Cramton T., Trollfors B. Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J. Pediatr. 1989; 114: 97–100
   PubMed Web of Science ®Google Scholar
• Daum R. S., Siber G. R., Ballanco G. A., Sood S. K. Serum anticapsular antibody response in the first week after immunization of adults and infants with the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J. Infect. Dis. 1991; 164: 1154–1159
   Google Scholar
• Siegrist C. A., Cordova M., Brandt C., Barrios C., Berney M., Tougne C., Kovarik J., Lambert P. H. Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine 1998; 16: 1409–1414
   PubMed Web of Science ®Google Scholar
• Siegrist C. A., Barrios C., Martinez X., Brandt C., Berney M., Cordova M., Kovarik J., Lambert P. H. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur. J. Immunol. 1998; 28: 4138–4148
   PubMed Web of Science ®Google Scholar
• Dagan R., Ashkenazi S., Amir J., Michaelowsky A., Kalmanovitch I., Bar A., YohaySafary A. High-dose inactivated Hepatitis A vaccine (HD-HAV-VAC) in infants: comparison of response in the presence versus absence of maternally-derived antibodies (Mat-Ab). Proceedings of the 38th Annual ICAAC. 1998
   Google Scholar
• Hassett D. E., Zhang J., Whitton J. L. Neonatal DNA immunization with a plas-mid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J. Virol. 1997; 71: 7881–7888
   PubMed Web of Science ®Google Scholar
• Manickan E., Yu Z., Rouse B. T. DNA immunization of neonates induces immunity despite the presence of maternal antibody. J. Clin. Invest. 1997; 100: 2371–2375
   PubMed Web of Science ®Google Scholar
• Monteil M., Le Potier M. F., Guillotin J., Cariolet R., Houdayer C., Eloit M. Genetic immunization of seronegative one-day-old piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams. Vet. Res. 1996; 27: 443–452
   PubMed Web of Science ®Google Scholar
• Le Potier M. F., Blanquefort P., Morvan E., Albina E. Results of a control programme for the porcine reproductive and respiratory syndrome in the French ‘Pays de la Loire’ region. Vet. Microbiol. 1997; 55: 355–360
   Google Scholar
• Wang Y., Xiang Z., Pasquini S., Ertl H. C. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus. J. Virol. 1998; 72: 1790–1796
   PubMed Web of Science ®Google Scholar
• Bangham C. R. Passively acquired antibodies to respiratory syncytial virus impair the secondary cytotoxic T-cell response in the neonatal mouse. Immunology 1986; 59: 37–41
   Google Scholar
• Mc Graw T. T. Reimmunization following early immunization with measles vaccine: a prospective study. Pediatrics 1986; 77: 45–48
   Google Scholar
• Stetler H. C., Orenstein W. A., Bernier R. H., Herrmann K. L., Sirotkin B., Hopfensperger D., Schuh R., Albrecht P., Lievens A. W., Brunell P. A. Impact of revaccinating children who initially received measles vaccine before 10 months of age. Pediatrics 1986; 77: 471–476
   Google Scholar
• Kurikka S., Olander R. M., Eskola J., Kayhty H. Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy. Pediatr. Infect. Dis. J. 1996; 15: 530–535
   Google Scholar
• Cherry J. D., Feigin R. D., Shackelford P. G., Hinthom D. R., Schmidt R. R. A clinical and serologic study of 103 children with measles vaccine failure. J. Pediatr. 1973; 82: 802–808
   PubMed Web of Science ®Google Scholar
• Ward J. Abstract 984. Proceedings ICAAC. 1992
   Google Scholar
• Goldschneider I., Lepow M. L., Gotschlich E. G., Mauck F. T., Bachl F., Randolph M. Immunogenicity of group A and group C meningococcal poly-saccharides in human infants. J. Infect. Dis. 1973; 128: 769–776
   PubMed Web of Science ®Google Scholar
• Gold R., Lepow M. L., Goldschneider I., Gotschlich B. C. Immune response of human infants of polysaccharide vaccines of group A and C. Neisseria meningitidis. J. Infect. Dis. 1977; 136: S31–S35, Suppl.
   PubMed Web of Science ®Google Scholar
• Leach A., Twumasi P. A., Kumah S., Banya W. S., Jaffar S., Forrest B. D., Granoff D. M., Li D. E., ButtiCarlone G. M., Pais L. B., Broome C. V., Greenwood B. M. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J. Infect. Dis. 1997; 175: 200–204
   PubMed Web of Science ®Google Scholar
• Provenzano R. W., Wetterlow L. H., Sullivan C. L. Immunization and antibody response in the newborn infant. N. Engl. J. Med. 1965; 273: 959–965
   PubMed Web of Science ®Google Scholar
• Baraff L. J., Leake R. D., Burstyn D. G., Payne T., Cody C. L., Manclark C. R., St J. W. Geme Jr., Immunologic response to early and routine DTP immunization in infants. Pediatrics 1984; 73: 37–42
   PubMed Web of Science ®Google Scholar